Related Experiment Videos
Memory and mental status correlates of modified Braak staging
E Grober1, D Dickson, M J Sliwinski
1Department of Neurology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA. egrober@dti.net
Neurobiology of Aging
|February 16, 2000
Summary
Alzheimer's disease neuropathology, staged using Braak staging, correlates with cognitive decline. Memory impairment appears earlier than general mental status decline in Alzheimer's patients.
Area of Science:
- Neuropathology
- Neuroscience
- Gerontology
Background:
- Alzheimer's disease (AD) is characterized by progressive neurodegeneration.
- Braak staging categorizes AD neuropathology based on neurofibrillary tangle distribution.
- Understanding the relationship between neuropathologic stage and cognitive decline is crucial for AD research.
Purpose of the Study:
- To assess the relationship between Braak neuropathologic stage and cognitive performance in Alzheimer's disease.
- To determine if memory decline precedes general mental status decline in relation to AD progression.
Main Methods:
- Prospective clinicopathologic study of 29 Alzheimer's disease patients.
- Neuropathologic staging using Braak and Braak criteria with tau immunocytochemistry.
- Assessment of memory and mental status using standardized cognitive tests.
Main Results:
- Higher Braak stages correlated with poorer performance on both memory and mental status tests.
- Memory performance declined significantly between Braak stages II and III.
- Mental status decline was observed later, between stages III and IV.
- The association between memory and Braak stage remained after adjusting for senile plaques.
- Adjusting for Braak stage removed the link between amyloid burden and cognitive function.
Conclusions:
- Braak staging effectively summarizes Alzheimer's disease neuropathology.
- Braak staging is closely associated with both memory and mental status performance in AD.
- Memory deficits manifest earlier in the neuropathologic progression of Alzheimer's disease than broader cognitive impairments.